Literature DB >> 6532804

In vitro metabolism of procyclidine in the rat.

G Paeme, R Grimee, A Vercruysse.   

Abstract

Procyclidine, 1-cyclohexyl-1-phenyl-3-(1-pyrrolidinyl)-1-propanol, was incubated with the 9000g supernatant fraction of rat liver homogenates, fortified with a NADPH generating system. Three major metabolites were isolated from the incubation mixture. They were identified as 1-(cis-4-hydroxycyclohexyl)-1-phenyl-3-(1-pyrrolidinyl)-1-propanol, 1-(trans-4-hydroxycyclohexyl)-1-phenyl-3-(1-pyrrolidinyl)-1-propanol, and (1R*, 3R*, 7S(R?)*)-1-(trans-3-hydroxycyclohexyl)-1-phenyl-3-(1-pyrrolidinyl) -1-propanol. The latter has not been detected previously in rat urine and probably represents an intermediate metabolite.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6532804     DOI: 10.1007/BF03189682

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  3 in total

1.  Kemadrin in the treatment of parkinsonism.

Authors:  R S SCHWAB; M E CHAFETZ
Journal:  Neurology       Date:  1955-04       Impact factor: 9.910

2.  Isolation and identification of eight procyclidine metabolites from rat urine.

Authors:  G Paeme; R Grimee; A Vercruysse
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1984 Apr-Jun       Impact factor: 2.441

3.  A comparison of piribedil, procyclidine and placebo in the control of phenothiazine-induced parkinsonism.

Authors:  R H Mindham; P Lamb; R Bradley
Journal:  Br J Psychiatry       Date:  1977-06       Impact factor: 9.319

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.